SINOPHARM (01099): China National Accord Medicines Corporation (000028.SZ) expects the net profit attributable to the parent in 2025 to be approximately 10.55 billion to 12.15 billion yuan, a year-on-year increase of 64.20% to 89.11%.
China National Pharmaceutical Group (01099) announced that it is expected that China National Pharmaceutical Group (000028.SZ) will achieve a net profit attributable to the shareholders of the listed company of 10.55 billion to 12.15 billion yuan in 2025, a year-on-year increase of 64.20% to 89.11%. It is expected that the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses will be 9.96 billion to 11.56 billion yuan in 2025, a year-on-year increase of 71.38% to 98.91%.
SINOPHARM (01099) announced that China National Accord Medicines Corporation (000028.SZ) is expected to achieve a net profit attributable to shareholders of the listed company of 10.55 billion to 12.15 billion yuan in 2025, a year-on-year increase of 64.20% to 89.11%. It is expected to achieve a net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, of 9.96 billion to 11.56 billion yuan in 2025, a year-on-year increase of 71.38% to 98.91%.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
